Timeline of brain cancer

This is a timeline of brain cancer, describing especially major discoveries, advances in treatment and major organizations.

Big picture

Year/period

Key developments

19th century

First record on discovery of brain cancer. First surgery for a brain tumor is performed in this century.

1920s

Electroencephalograms (EEG) in humans develop as a method to record activity in the brain.

1970s

Computed tomography (CT) scanning is developed and provides first clear image of brain tumors. First promising chemotherapy for glioma is developed. Radiation is established as standard treatment for glioblastoma.

1980s

Magnetic resonance imaging is introduced and gains widespread use. It eventually replaces CT scanning as The Primary imaging tool for brain tumors. Gamma knife therapy is introduced for treating brain tumors.

1990s

Advances in chemotherapy and radiation increases survival for patients. Classification for brain tumors unifies into one universal system.

2000s

The Cancer Genome Atlas project launches.

2010s

Today, cancer immunotherapy is being actively studied. Primary brain tumors occur in around 250,000 people a year globally, making up less than 2% of cancers. Figures for incidence on brain cancer show predominance in more developed countries.

Full timeline

Year/period

Type of event

Event

Location

1873

Discovery

Russian scientist Gupta Longati first discovers brain cancer.

1879

Achievement

Scottish surgeon William Macewen performs the first successful brain tumor removal in a young woman.

1904

Development

Medulloepithelioma (a rare brain tumor thought to stem from cells of the embryonic medullary cavity) is first described by Frederick Verhoeff.

1907

Development

First description of the clinical syndrome of neuroblastoma of the adrenals by English surgeon Jonathan Hutchinson. However, the pathologic interpretation of the disease is not established until several years later.

1908

Development

Subependymal giant cell astrocytoma (a low-grade astrocytic brain tumor) is first described.

1918

Development

Pilocytic astrocytoma (a brain tumor that occurs more often in children and young adults) is first described.

1920

Development

Lhermitte–Duclos disease (rare tumor of the cerebellum) is first described by French neurologist Jacques Jean Lhermitte and P. Duclos.

1925

Development

Medulloblastoma (the most common type of pediatric malignant primary brain tumor) is first described.

1926

Development

Percival Bailey and Harvey Cushing introduce the term glioblastoma multiforme, based on the idea that the tumor originates from primitive precursors of glial cells (glioblasts), and the highly variable appearance due to the presence of necrosis, hemorrhage and cysts (multiform).

1930

Development

Astroblastoma, a rare glial tumor, is first described.

1936

Development

American neurophysiologist William Grey Walter first identifies the association between localized slow waves on electroencephalograms and tumors of the cerebral hemispheres. The term "delta waves" is introduced by Walter.

1936

Development

Optic nerve sheath meningioma (a rare benign tumor of the optic nerve), is first described.

1938

Gliomatosis cerebri (a rare primary brain tumor) is first described.

1942

Development

Hemangiopericytoma (a tumor located in the cerebral cavity) is first characterized.

1945

Development

Subependymoma (a rare form of ependymal tumor) is first described.

1955

Development

Choroid plexus papilloma (a rare benign neuroepithelial intraventricular WHO grade I lesion found in the choroid plexus) is first reported.

1958

Treatment

Dexamethasone is first synthesized. To date it remains the most favorable [...] for brain cancer patients.

1971

Development

Trilateral retinoblastoma (a malignant midline primitive neuroectodermal tumor occurring in patients with retinoblastoma) is first described.

1971

Development

British company EMI develops CT scanner that provides pictures of patients brains to be seen for the first time.

UK

1973

Organization

American Brain Tumor Association is founded as a nonprofit organization. It provides support services and programs to brain tumor patients and their families, and funds brain tumor research.

Chicago, Illinois, US

1975

Treatment

Radiation therapy becomes standard treatment for glioblastoma, showing it extends median survival from 3 months to about 9 months in patients.

1978

Development

Researchers at EMI Laboratories obtain the first Magnetic resonance imaging (MR) of a human brain.

UK

1979

Development

Pleomorphic Xanthoastrocytoma (a rare tumor located throughout the supratentorial compartment in the brain) is first described.

1982

Development

Central neurocytoma (an extremely rare, ordinarily benign intraventricular brain tumour), is first described.

1988

Organization

The Children's Brain Tumor Foundation is established. It funds research in brain cancer.

New York City, US

1993

Discovery

Large analysis shows that adding chemotherapy to radiation therapy helps patients with surgically treated malignant gliomas live longer compared to radiation therapy alone.

1993

Development

World Health Organization develops universal system for classifying brain tumors with aims at improving communication and translate research findings.

1994

Development

The first study of the human brain at 3.0 T is published.

1994

Development

US National Cancer Institute establishes brain tumor research networks for adults and children, comprising brain cancer experts from academic centers who collaborate to evaluate novel therapies against brain cancer.

United States

1996

Discovery

Researchers at University of Washington find that brain cancer is related to low levels of protein MGMT.

United States

1996

Development

Giant cell ependymoma (an uncommon neuroepithelial tumor located in the central nervous system) is first described.

1997

Development

Researchers at Washington University first develop susceptibility weighted imaging, which can help determine the status of a tumor in the brain.

US

1997

Treatment

British doctors make use of first laser system to treat brain tumors by destroying cancerous tissue.

UK

1998

Development

The first study of the human brain at 8 T is published.

1998

Organization

The German Brain Tumor Association (Deutsche Hirntumorhilfe) is founded. It supports research especially in the field of neurooncology.

Leipzig, Germany

2001

Achievement

First successful application of retroviral replicating vectors towards transducing cell lines derived from solid tumors.

2001

Organization

Accelerate Brain Cancer Cure is founded as a nonprofit organization. It awards grants to leading brain cancer researchers and partners with the medical, academic, business, and government sectors.

Washington, DC., US

2003

Treatment

Use of chemotherapy wafer containing carmustine (BCNU) is found to delay tumor growth and improve overall survival in some patients with gliomas.

2004

Treatment

International study shows that giving low doses of temozolomide at the start of the treatment proves very effective against brain cancer.

2005

Discovery

Researchers discover that patients with tumors carrying a specific alteration in a gene MGMT benefit from temozolomide (Temodar) therapy.

2005

Study

US National Cancer Institute and US National Genome Research Institute launch The Cancer Genome Atlas Project, with the goal of mapping the genetic changes involved in glioblastoma and other cancers.

United States

2005

Development

Angiocentric Glioma (a tumor of the central nervous system), is described.

2006

Discovery

Researchers discover distinct subtypes of astrocytoma tumors, each one with unique biological features that appear to influence the tumor's behavior and response to certain therapies.

2008

Discovery

Researchers find that family members of patients with brain cancer, particularly astrocytoma, may inherit a higher risk of the same diagnosis.

2008

Discovery

The Cancer Genome Atlas Project reports the identification of several key mutations in the ERBB2, NF1 and TP53 genes, that are involved in triggering the development and spread of glioblastoma.

United States

2008

Treatment

FDA approves bevacizumab to treat glioblastoma.

United States

2009

Discovery

Researchers discover that tumors with an alteration in the IDH1 or IDH2 genes are less aggressive than those without the mutation. This finding would eventually enable some patients to safely undergo less intense therapy.

2010

Discovery

Set of nine genes is found to predict the likelihood that a glioblastoma will respond to therapy.

2013

Development

Researchers develop new technique to distinguish tumors from healthy tissue in the brain, using raman scattering microscopy.

US

2016

Discovery

Study finds that people with higher levels of education may be more likely to develop certain types of brain tumors.

Sweden

See also

  • Timeline of colorectal cancer
  • Timeline of pancreatic cancer
  • Timeline of kidney cancer
  • Timeline of lung cancer
  • Timeline of liver cancer
  • Timeline of bladder cancer
  • Timeline of cervical cancer